analyst
TE
NASDAQ · TENX
Tenax Therapeutics, Inc.
Healthcare · Biotechnology
$1.36
Down-$0.15 (-9.93%)
Updated Oct 19, 2026, 12:15 PM
SID Score
2.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 45.01M
- P/E ratio
- -12.4
- Dividend yield
- 0.00%
- 52-week range
- $1.31 – $19.40
- Volume
- 1.86M
- Avg. volume
- 113.76K
Price performance · TENX
TENX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
TENX closed at $1.36 after 20 trading sessions, down 27.66% for the selected period.
- Last close
- $1.36
- Period change
- -27.66%
- Period low
- $1.36
- Period high
- $1.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $1.51 | $1.52 | $1.36 | $1.36 | 1.86M |
| Oct 15, 2026 | $1.55 | $1.56 | $1.51 | $1.51 | 2.01M |
| Oct 14, 2026 | $1.60 | $1.65 | $1.53 | $1.535 | 1.96M |
| Oct 13, 2026 | $1.84 | $1.84 | $1.58 | $1.60 | 7.68M |
| Oct 12, 2026 | $1.88 | $1.88 | $1.83 | $1.83 | 790.57K |
| Oct 9, 2026 | $1.86 | $1.91 | $1.80 | $1.87 | 2.35M |
| Oct 8, 2026 | $1.91 | $1.91 | $1.825 | $1.86 | 2.41M |
| Oct 7, 2026 | $1.92 | $1.95 | $1.8902 | $1.91 | 701.61K |
| Oct 6, 2026 | $1.96 | $1.995 | $1.90 | $1.93 | 1.18M |
| Oct 5, 2026 | $1.98 | $1.99 | $1.88 | $1.96 | 1.47M |
| Oct 2, 2026 | $1.96 | $2.00 | $1.92 | $1.98 | 2.03M |
| Oct 1, 2026 | $1.905 | $1.96 | $1.87 | $1.93 | 2.29M |
| Sep 30, 2026 | $1.84 | $1.92 | $1.80 | $1.89 | 4.22M |
| Sep 29, 2026 | $1.83 | $1.89 | $1.81 | $1.84 | 2.27M |
| Sep 28, 2026 | $1.81 | $1.88 | $1.80 | $1.85 | 2.21M |
| Sep 25, 2026 | $1.88 | $1.93 | $1.81 | $1.81 | 2M |
| Sep 24, 2026 | $1.89 | $1.915 | $1.80 | $1.89 | 4.08M |
| Sep 23, 2026 | $1.91 | $1.94 | $1.855 | $1.90 | 2.35M |
| Sep 22, 2026 | $1.88 | $1.95 | $1.88 | $1.94 | 2.19M |
| Sep 21, 2026 | $1.88 | $1.92 | $1.86 | $1.88 | 2.14M |
Latest TENX news
The latest Smart Investors Daily articles mentioning TENX.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

